INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined strawberries. Clear

An expert overview of the literature, useful as background reading.

2 studies

2012 / Editorial / commentary on a randomized phase II trial

A commentary reports that 60 g/day of strawberry powder reduced the histologic grade of dysplastic lesions in an esophageal cancer prevention trial.

This commentary discusses a randomized noncomparative phase II trial in China testing two doses of strawberry powder (60 g/d or 30 g/d for six months) to prevent esophageal cancer. The 60 g/d dose reduced the histologic grade of dysplastic lesions and reduced localized biomarkers, whereas the 30 g/d dose was not effective. The author notes that fundamental questions remain regarding formulation, active components, and mechanisms of action.

Suh N, Pezzuto JM Cancer Prev Res (Phila), 2012. PMID 22219164

2012 / Narrative review

Plant polyphenols, including grape and blueberry juices, show potential in the treatment of cognitive impairment in preliminary human trials and rodent studies.

This review discusses the potential role of plant polyphenols and fruit products in treating age-related cognitive disorders and dementia. Blueberry, strawberry, blackberry, grape, and plum juices or extracts have been tested in cognitively impaired rodents, and small human trials have examined grape and blueberry juice. Specific polyphenols like resveratrol and pterostilbene have been studied or shown to improve cognition in rodents. Future human trials need to consider poor bioavailability, optimal timing of therapy, and the appropriate form of treatment.

Cherniack EP Br J Nutr, 2012. PMID 22475317